← Open Payments lookup

ASHLEY SCHWASS: Open Payments

NPI 1891190724 · BERKELEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,109 in 42 payments from 25 companies in 2025. Trend: 2023 $284 · 2024 $433 · 2025 $1,109

Food & beverage: $934Education: $175
CompanyPaymentsAmount
Astellas Pharma US Inc3$116
AstraZeneca Pharmaceuticals LP4$103
SEAGEN INC.1$84
Janssen Biotech, Inc.3$82
Novartis Pharmaceuticals Corporation3$81
Merck Sharp & Dohme LLC3$77
E.R. Squibb & Sons, L.L.C.2$52
Takeda Pharmaceuticals U.S.A., Inc.2$48
GlaxoSmithKline, LLC.2$47
PFIZER INC.2$41

Products named: KEYTRUDA, OPDIVO, TAGRISSO, JEMPERLI, Xtandi, BRAFTOVI, CARVYKTI, Amtagvi.

Industry payments across CA — which companies pay providers there.